Vanguard B Injectable is licensed for the vaccination of healthy dogs 8
weeks of age or older as an aid in the control of canine infectious
tracheobronchitis (kennel cough) caused by Bordetella bronchiseptica
(Bb). BRONCHICINE CAe is prepared from antigenic material extracted from
the Bordetella bronchiseptica organism. A immunogenic strain of B.
bronchiseptica is grown to a high yield, then subjected to a proprietary
process which extracts the antigens from the B. bronchiseptica cells.
The residual cell debris is then removed, resulting in a product which
retains the desirable immunologic qualities of a whole cell bacterin,
while helping reduce toxic and other undesirable side effects with whole
cell bacterins. Vanguard B Injectable is a killed cellular extract of
the Bordetella bronchiseptica organism.